José A. G. Agúndez, MD, Ph D. (José Augusto García-Agúndez Pérez-Coca)
José A. G. Agúndez, MD, Ph D. (José Augusto García-Agúndez Pérez-Coca)
Professor. University Institute of Molecular Pathology Biomarkers. ARADyAL.
Verified email at
Cited by
Cited by
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23. 3
IPM Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, K Howarth, ...
Nature genetics 40 (5), 623-630, 2008
Cytochrome P450 gene polymorphism and cancer
JAG Agúndez
Current drug metabolism 5 (3), 211-224, 2004
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209-217, 2014
Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism
M Oscarson, RA McLellan, H Gullstén, JAG Agúndez, J Benı́tez, A Rautio, ...
FEBS letters 460 (2), 321-327, 1999
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population
JAG Agúndez, MC Ledesma, JM Ladero, J Benítez
Clinical Pharmacology & Therapeutics 57 (3), 265-269, 1995
Glutathione S‐transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug‐induced liver injury
MI Lucena, RJ Andrade, C Martínez, E Ulzurrun, E García‐Martín, ...
Hepatology 48 (2), 588-596, 2008
Characteristics of subjects experiencing hypersensitivity to non‐steroidal anti‐inflammatory drugs: patterns of response
I Doña, N Blanca‐López, JA Cornejo‐García, MJ Torres, JJ Laguna, ...
Clinical & Experimental Allergy 41 (1), 86-95, 2011
Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms
E García‐Martín, C Martínez, B Tabarés, J Frías, JAG Agúndez
Clinical Pharmacology & Therapeutics 76 (2), 119-127, 2004
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2‐receptor antagonists
C Martínez, C Albet, JAG Agúndez, E Herrero, JA Carrillo, M Márquez, ...
Clinical Pharmacology & Therapeutics 65 (4), 369-376, 1999
CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
E García‐Martín, C Martínez, RM Pizarro, FJ García‐Gamito, H Gullsten, ...
Clinical pharmacology & therapeutics 71 (3), 196-204, 2002
Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals
E García-Martín, C Martínez, JM Ladero, JAG Agundez
Molecular diagnosis & therapy 10 (1), 29-40, 2006
Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use
C Martínez, G Blanco, JM Ladero, E García‐Martín, C Taxonera, ...
British journal of pharmacology 141 (2), 205-208, 2004
Venographic comparison of subcutaneous low–molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
JA Gonzalez-Fajardo, E Arreba, J Castrodeza, JL Perez, L Fernandez, ...
Journal of vascular surgery 30 (2), 283-292, 1999
The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)‐ibuprofen enantiomer in healthy subjects
C Martínez, E García‐Martín, G Blanco, FJG Gamito, JM Ladero, ...
British journal of clinical pharmacology 59 (1), 62-68, 2005
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis
SJ McCann, SM Pond, KM James, DG Le Couteur
Journal of the neurological sciences 153 (1), 50-53, 1997
Polymorphisms of human N-acetyltransferases and cancer risk
JAG Agundez
Current drug metabolism 9 (6), 520-531, 2008
Changing the Si distribution in SAPO-11 by synthesis with surfactants improves the hydroisomerization/dewaxing properties
T Blasco, A Chica, A Corma, WJ Murphy, J Agúndez-Rodríguez, ...
Journal of Catalysis 242 (1), 153-161, 2006
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy
B Moriyama, AO Obeng, J Barbarino, SR Penzak, SA Henning, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (1), 45-51, 2017
High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.
E García-Martín, C Martínez, JM Ladero, FJG Gamito, JAG Agúndez
European journal of clinical pharmacology 57 (1), 47-49, 2001
Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes
MH Court, SX Duan, LM Hesse, K Venkatakrishnan, DJ Greenblatt
The Journal of the American Society of Anesthesiologists 94 (1), 110-119, 2001
The system can't perform the operation now. Try again later.
Articles 1–20